
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study
Author(s) -
Giovanni Schifitto,
Bradford Navia,
Constantin T. Yiannoutsos,
Christina M. Marra,
Linda Chang,
Thomas Ernst,
Jeffrey G. Jarvik,
Eric N. Miller,
Elyse J. Singer,
Ronald J. Ellis,
Dennis L. Kolson,
David M. Simpson,
Avindra Nath,
Joseph Berger,
S. Shriver,
Linda Millar,
Dodi Colquhoun,
Robert E. Lenkinski,
R. Gilberto González,
Stuart A. Lipton
Publication year - 2007
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32813384e8
Subject(s) - memantine , placebo , medicine , neuropsychology , dementia , nmda receptor , psychology , anesthesia , psychiatry , cognition , pathology , receptor , alternative medicine , disease
To assess the safety and efficacy of memantine, an uncompetitive antagonist of the N-methyl-D-aspartate receptor as treatment of HIV-associated cognitive impairment.